New York Attorney General Eric Schneiderman today applauded the U.S. Supreme Court’s decision that pay-for-delay settlements of drug-patent litigation may be challenged as potential violations of antitrust law.
The ruling is a “victory” for millions of Americans who depend on generic drugs to treat illness and pain, Schneiderman said in the news release.
“As we argued in our brief to the Supreme Court, pay-for-delay drug settlements should receive serious scrutiny because they are frequently anticompetitive, unlawful, and harmful to health-care consumers across the country. This decision makes clear that drug companies can be sued to stop anticompetitive pay-for-delay agreements. It will be an important weapon in the fight for affordable drug prices and quality healthcare for every citizen,” Schneiderman said.
(Sponsored)
Can a Generative AI Use Policy for the Workplace Help Protect Sensitive Data?
Artificial intelligence is a buzzword for many industries. It has good and bad effects on the future of creating content, finding information, and other uses. So, what does this mean
Inflation and Insurance Rates: How to Offset the Impact
Many industries have been hit by inflation where it hurts the most, our pockets. Inflation is raising the price of goods and services including food, housing, transportation, and medical care.
Schneiderman in January led a coalition of 36 states, plus the District of Columbia and the Commonwealth of Puerto Rico, in arguing that the Supreme Court should allow antitrust enforcers to challenge pay-for-delay settlements as anticompetitive and unlawful, according to the news release.
Contact Reinhardt at ereinhardt@cnybj.com
